Baxter Bros’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Baxter Bros's VRTX Position: Q3 2026 in Review
Baxter Bros reduced its Vertex Pharmaceuticals (VRTX) stake by 3.3% in Q3 2026, selling an estimated $24.6K and leaving 1,393 shares worth $728K. The position accounts for 0.08% of the portfolio, ranked #109.
Baxter Bros first reported a position in VRTX in Q4 2020 and has held it in 24 quarters since. The position peaked at $752K in Q4 2020. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Baxter Bros held 1,393 shares of Vertex Pharmaceuticals worth $728K as of Q3 2026.
- Baxter Bros sold 48 Vertex Pharmaceuticals shares in Q3 2026, an estimated $24.6K.
- Vertex Pharmaceuticals made up 0.08% of Baxter Bros's portfolio in Q3 2026, its #109 holding.
- Baxter Bros first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Baxter Bros's Vertex Pharmaceuticals position peaked at $752K in Q4 2020.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Baxter Bros's 13F filing for Q3 2026, filed 4 Nov 2026.